BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with HER2 Positive Metastatic Gastric Cancer at Interim Analysis of DESTINY-Gastric04 Phase 3 Trial

  March 3, 2025

   · 

  19 min read
• Press Releases

  Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study

  March 3, 2025

   · 

  5 min read
• Press Releases

  Delta-Fly Pharma, Inc.: Progress of Development Status of the Combination Study of DFP-10917 with Venetoclax

  March 3, 2025

   · 

  1 min read
• Press Releases

  ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

  March 3, 2025

   · 

  33 min read
• Press Releases

  Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

  March 3, 2025

   · 

  19 min read
• Press Releases

  Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)

  March 3, 2025

   · 

  12 min read
• Press Releases

  Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference

  March 3, 2025

   · 

  1 min read
• Press Releases

  BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines

  March 3, 2025

   · 

  14 min read
• Press Releases

  Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration

  March 3, 2025

   · 

  7 min read
• Press Releases

  CHMP recommends EU approval of Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

  March 3, 2025

   · 

  10 min read